Get a glimpse on Insulin Resistance Market!

Insulin Resistance – Global API Manufacturers, Marketed and Phase III Drugs Landscape 2018, the report provides comprehensive insights about marketed and Phase III products for Insulin Resistance. The report includes information on marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country.

 

Insulin Resistance Market Size
Insulin Resistance Market and Forecast 2020

 

Global API Manufacturers of Marketed Products for Insulin Resistance

Coverage of API manufacturers for Insulin Resistance marketed products spanning across United States, Europe, China, and India. The manufacturers’ details include manufacturers’ name along with their location.

Emerging Phase III products for Insulin Resistance

This report provides a comprehensive understanding of the emerging Phase III therapies for Insulin Resistance which can turn out to be future prospective competitors for the marketed products. It will also put light on the current market trends. Their forecasted global sales are also provided till 2020.

Methodology

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by the DelveInsight team of industry experts.

Secondary information and data have been collected from various printable and non-printable sources like search engines, news websites, government websites, trade journals, white papers, magazines, trade associations, books, industry portals, industry associations, and available databases.

Scope

  • A review of the marketed products for Insulin Resistance including their description, route of synthesis, regulatory milestones, forecasted sales estimates till 2020 and API manufacturer details.
  • Patent information coverage of the marketed products including the patent number, holder, grant and patent expiry details.
  • API manufacturers for the marketed products with location details.
  • Emerging Phase III product profiles for Insulin Resistance including product description, developmental activities, licensors & collaborators and chemical information.

Reasons to Buy

  • API intelligence for marketed drugs for the indication and gaining insights of API manufacturers.
  • Evaluate the marketing status and patent details of products to exploit opportunities for generic drug development.
  • Design effective counter-strategies to gain the competitive advantage by identifying the key patent expiry details and exclusivity with respect to the indication.
  • Establish a comprehensive understanding of the emerging Phase III products which can be future competitors in this space.

Category: Healthcare Market Research

Contact Details:

Aarkstore Enterprise

+91 7710006788 | contact@aarkstore.com | aarkstore.com

Diabetic Peripheral Neuropathy, on a research ground!

Diabetic Peripheral Neuropathy – Pipeline Insights, 2017

The report provides comprehensive insights into the ongoing therapeutic research and development across Diabetic Peripheral Neuropathy. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Diabetic Peripheral Neuropathy by development stage, therapy type, route of administration and molecule type is also covered in the report. It also has a special feature on the inactive pipeline products in this area.

 

Pipeline Insights - Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathy Pipeline Insights

 

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Scope of the report

  • The report provides a snapshot of the pipeline development for the Diabetic Peripheral Neuropathy.
  • The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Diabetic Peripheral Neuropathy.
  • The report provides pipeline product profiles which include product description, developmental activities, licensors & collaborators and chemical information.
  • Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Diabetic Peripheral Neuropathy.

The report also covers the dormant and discontinued pipeline projects related to the Diabetic Peripheral Neuropathy.

Reasons to Buy

  • Establish a comprehensive understanding of the pipeline activity across this Diabetic Peripheral Neuropathy to formulate effective R&D strategies.
  • Gather information of the emerging competitors having a potentially lucrative portfolio in this space and create effective counter-strategies to gain competitive advantage.
  • Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
  • Plot corrective measures for pipeline projects by understanding the pipeline depth and focus of Diabetic Peripheral Neuropathy Therapeutics.
  • Devise in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Modify the therapeutic portfolio by identifying inactive projects and understanding the factors that might have halted their progress.

Category: Healthcare Market Research

Contact Details:

Aarkstore Enterprise
+91 7710006788 | contact@aarkstore.com | aarkstore.com

Hepatitis D, an Overview !

Hepatitis D-Pipeline Insights, 2017, the report provides comprehensive insights of the ongoing therapeutic research and development across Hepatitis D. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Hepatitis D by development stage, therapy type, route of administration and molecule type is also covered in the report. It also has a special feature on the inactive pipeline products in this area.

 

Hepatitis D Pipeline Insight
Hepatitis D Pipeline Insight | Research and Reports

 

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts. Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

The scope of the report

• The report provides a snapshot of the pipeline development for the Hepatitis D
• The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Hepatitis D
• The report provides pipeline product profiles which include product description, developmental activities, licensors & collaborators and chemical information
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Hepatitis D
• The report also covers the dormant and discontinued pipeline projects related to the Hepatitis D

Reasons to Buy

• Establish a comprehensive understanding of the pipeline activity across this Hepatitis D to formulate effective R&D strategies
• Gather information of the emerging competitors having a potentially lucrative portfolio in this space and create effective counter-strategies to gain competitive advantage
• Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine
• Plot corrective measures for pipeline projects by understanding the pipeline depth and focus of Hepatitis D therapeutics
• Devise in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Modify the therapeutic portfolio by identifying inactive projects and understanding the factors that might have halted their progress

Category: Healthcare Market Research

Contact Details:

Aarkstore Enterprise

+91 7710006788 | contact@aarkstore.com | aarkstore.com

In Vitro Fertilization IVF in Growth!

In-vitro fertilization (IVF) has become an established treatment option for different forms of infertility. IVF procedures help infertile people to conceive. IVF provides women the opportunity to become pregnant using her own eggs or donor’s eggs and sperm from her partner or from a sperm donor. As the IVF procedure is quite expensive, people generally try out other options. In case of failure in other treatments, IVF remains as the only option for the people longing to experience parenthood. Additionally, in certain cases, IVF is chosen if the parents are fearful of passing certain genetic disorders to the child. The embryos can be tested for genetic abnormalities in medical labs prior to implantation.

In vitro fertilization Market Reports
In Vitro Fertilization IVF Market Research

 

The factors such as the rise in the rate of infertility and surrogacy in developing countries, increasing occurrence of reproductive tourism, and high success rate of IVF are anticipated to be the drivers for the growth of the market. Additionally, the changing lifestyle in urban areas and increased age of parenthood are expected to boost the growth of the market. Despite the drivers, the high cost related to assisted reproductive techniques (ART) may hamper the growth of the global in-vitro fertilization market.

IVF Market Segmentation:

  • The global in-vitro fertilization market has been segmented based on product, type, end-user, and region.
  • Based on the product, the market is segmented into devices and reagents. The devices segment is further segmented into imaging systems, sperm separation system, ovum aspiration pump, cerosystem, and the micromanipulator. The reagent segment is segmented into embryo culture media, cryopreservation media, sperm processing media, and ovum processing media.
  • Based on the type, the market is segmented into intrauterine insemination (IUI), in-vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and IVF using donor eggs.
  • Based on end-user, the market is segmented into fertility clinics, hospitals, clinical research centers, and others.

The global in-vitro fertilization market is expected to register a CAGR of 10.50% during the forecast period from 2018 to 2023.

Study objectives:

  • To provide a detailed analysis of the market structure along with the forecast of various segments and sub-segments of the in-vitro fertilization market.
  • To provide insights into factors affecting the market growth.
  • To analyze the global in-vitro fertilization market based on various tools such as supply chain analysis and Porter’s five force analysis.
  • To provide historical and forecast revenue of market segments and sub-segments with respect to regions and their respective key countries.
  • To provide country-level analysis of the market with respect to the current market size and future perspective.
  • To provide country-level analysis of the market for segments by product, type, end-user, and region.
  • To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies and drawing a competitive landscape for the market.
  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the in-vitro fertilization market.

Target Audience:

  • IVF device manufacturers & suppliers
  • Biotechnology companies
  • Fertility clinics
  • Hospitals & clinics
  • Academic research institutes
  • Government institutes

Key Findings:

  • The global in-vitro fertilization market is expected to register a CAGR of 10.50% during the forecast period from 2018 to 2023.
  • Based on the product, the devices segment accounted for the largest market share of 53.5% in 2017, with a market value of USD 3,739.7 million in 2017.
  • Based on the type, the intrauterine insemination (IUI) segment accounted for the largest market share of 35.4% in 2017, with a market value of USD 2,470.3 million.
  • Europe holds the largest share of the global in-vitro fertilization market which is expected to reach USD 5,074.1 million by 2023.
  • Asia-Pacific is the fastest growing market, which is expected to register a CAGR of 11.05 % from 2018 to 2023.

Regional Analysis: US, Canada, South America, Germany, France, UK, Italy, Spain, Japan, China, India, Australia, South Korea,

Category: Healthcare Market Research

Contact Details:

Aarkstore Enterprise
+91 7710006788 | contact@aarkstore.com | aarkstore.com

Dealing with Allergic Conjunctivitis | Knowing the Market

Allergic Conjunctivitis Market
Allergic Conjunctivitis Market Size, Future Forecast 2020

Global API Manufacturers of Marketed Products for Allergic Conjunctivitis

Coverage of API manufacturers for Allergic Conjunctivitis marketed products spanning across United States, Europe, China and India. The manufacturers details include manufacturers name along with their location.

Emerging Phase III products for Allergic Conjunctivitis

This report provides a comprehensive understanding of the emerging Phase III therapies for Allergic Conjunctivitis which can turn out to be future prospective competitors for the marketed products. It will also put light on the current market trends. Their forecasted global sales are also provided till 2020.

Methodology

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts. Secondary information and data has been collected from various printable and non-printable sources like search engines, news websites, government websites, trade journals, white papers, magazines, trade associations, books, industry portals, industry associations and available databases.

Scope

  • A review of the marketed products for Allergic Conjunctivitis including their description, route of synthesis, regulatory milestones, forecasted sales estimates till 2020 and API manufacturer details.
  • Patent information coverage of the marketed products including the patent number, holder, grant and patent expiry details.
  • API manufacturers for the marketed products with location details.
  • Emerging Phase III product profiles for Allergic Conjunctivitis including product description, developmental activities, licensors & collaborators and chemical information

Reasons to Buy

  • API intelligence for marketed drugs for the indication and gaining insights of API manufacturers.
  • Evaluate the marketing status and patent details of products to exploit opportunities for generic drug development.
  • Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to the indication.
  • Establish a comprehensive understanding of the emerging Phase III products which can be future competitors in this space.

For more inquiry contact our sales team at contact@aarkstore.com

Category: Healthcare

Related Reports:

Seasonal Allergic Rhinitis Global Clinical Trials Review, H2, 2018
Allergic Rhinitis – Pipeline Review, H2 2018
Bacterial Conjunctivitis – Pipeline Review, H2 2018
Viral Conjunctivitis – Pipeline Review, H2 2018

Contact Details:

Aarkstore Enterprise
+91 9987295242 | contact@aarkstore.comaarkstore.com

Global Cord Blood Banking – 2018 Industry Analysis | Aarkstore Market Research

Description

Over the past five years, the global cord blood banking industry has substantially matured and consolidated. This has created both serious threats and novel opportunities for the industry. Serious threats to the industry include low rates of utilization for stored cord blood, expensive cord blood transplantation procedures, difficulty educating obstetricians about cellular therapies, and an increasing trend toward industry consolidation.

Global Cord Blood Bank Industry
2018 Insight on Global Cord Blood Banking Industry

Digital competition for cord blood has also been growing increasingly competitive, with cord blood banks competing for online viewership of ads, website content, and ultimately, clients. Most cord blood banks are using Google Adwords to display advertisements within Google Search as a method of acquiring online visitors. Industry leaders are also publishing enormous quantities of industry-relevant content to dominate in organic (non-paid) online search.

However, there are also emerging opportunities for the industry, such as accelerated regulatory pathways for cell therapies in leading countries worldwide, including the U.S., Japan, and South Korea. Cord blood banks are diversifying into new types of stem cell storage, including cord tissue storage, placental stem cells, amniotic stem cells, menstrual stem cells, adipose tissue, and more.

Holding companies are emerging as a global theme, allowing for increased operational efficiency and economy of scale. Cryoholdco has been acquiring cord blood banks throughout Latin America and Sanpower Group has been purchasing them within Asia. Additionally, growing investment is flowing into cord blood stem cell expansion technologies. Key strategies being explored for this purpose include nicotinamide-mediated (NAM) expansion, Notch ligand, SR-1, UM171, PGE2, and enforced fucosylation. Major market players competing in this space include Gamida Cell Ltd, Nohla Therapeutics, Novartis, Fate Therapeutics, and others.

Reasons to buy

  • Today, cord blood banks now exist in every developed country, as well as within most developing nations. With approximately 450 companies marketing cord blood banking services worldwide, maturation of the market means that each company is fighting harder for market share. While the U.S. cord blood banking industry is the most mature cord blood banking market in the world, Asia is extremely close behind and growing more quickly than the U.S. market.

This 265 page reports includes:

  • Market size determinations by market segment
  • Trend data for umbilical cord blood grants, patents, and scientific publications
  • Clinical trial analysis, including comparison of cord blood vs. cord tissue
  • Rates of worldwide cord blood storage (units per year)
  • Current and future conditions treatable with cord blood
  • Probability of requiring a stem cell transplant by age
  • Regulatory pathways affecting cord blood banking in major healthcare markets
  • Digital marketing assessment and comparison of industry leaders
  • Competitive environment analysis, including identification of market leaders
  • Medical opinions of cord blood banking
  • Crucial trends and unmet market needs

For more inquiry contact our sales team at contact@aarkstore.com

Category: Healthcare

Related Report:

Complete 2017-18 Global Cord Blood Banking Industry Report

Contact Details:

Aarkstore Enterprise
+91 9987295242 | contact@aarkstore.comaarkstore.com